OTC · Drug Manufacturers - Specialty & Generic

Capha Pharmaceuticals Inc. (FPSUF) Stock

$0.00 OTC: FPSUF Healthcare

Capha Pharmaceuticals Inc. currently conducts very limited business operations.

Valuation

MetricValue
Price$0.00
Market Cap$6443
P/E Ratio-0.47
P/B Ratio-0.02
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA-537.06%
ROCE3.98%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.00
Current Ratio0.01

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$1.0M

Latest News

Global Times: China's innovation-driven growth can support more inclusive global development, says Arkebe Oqubay PR Newswire · Aug 6, 2026 You Sold the Big House and Banked $300K. These 3 ETFs Turn the Windfall Into a Monthly Check 24/7 Wall St. · Aug 6, 2026 Celestica Announces Pricing of Equity Offering Business Wire · Aug 6, 2026 JM Financial Ltd (BOM:523405) (Q1 2027) Earnings Call Highlights: Private Markets Surge Offsets ... GuruFocus.com · Aug 6, 2026 CE Info Systems Ltd (BOM:543425) (Q1 2027) Earnings Call Highlights: Revenue Up 14.9% to INR139. ... GuruFocus.com · Aug 6, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.17
EV / EBITDA-25.35
FCF Yield-217.84%
Quick Ratio0.01
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Capha Pharmaceuticals Inc.

Capha Pharmaceuticals Inc. currently conducts very limited business operations. Its strategic aim is to delve into and pursue opportunities within the pharmaceutical distribution industry. The company, which was founded in 2004, previously operated as FPS Pharma Inc. until it adopted its present name, Capha Pharmaceuticals Inc., in January 2017. It is headquartered in West Kelowna, Canada.

Capha Pharmaceuticals Inc. (FPSUF) stock trades at $0.00 with a market capitalization of $6443. The stock is valued at a price-to-earnings (P/E) ratio of -0.47, price-to-book of -0.02, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Capha Pharmaceuticals Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 3.98%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides